Harpoon Therapeutics Inc.

Harpoon Therapeutics Inc.

World Rank (Jan-05-2024)
18,428
Market Cap (Jan-05-2024)
0.181 Billion USD
World Rank (Jul-30-2023)
27,758
Market Cap (Jul-30-2023)
0.030 Billion USD
World Rank (Jan-07-2022)
18,940
Market Cap (Jan-07-2022)
0.199 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
HARP
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Company Website
HARPOON THERAPEUTICS, INC.
Company Profile

Harpoon Therapeutics, Inc is a clinical-stage immuno-oncology company designed for targeted penetration and destruction of solid tumors and hematologic malignancies and engineered to bind to human serum albumin for improved therapeutic schedule and patient convenience. The company annual revenue is 17.4 million USD and 171.5 million USD as on 2020. The headquarters is in USA.

Merck planning to buy Harpoon Therapeutics for 680 million USD and announced in January-2024.

IPO Year
2019
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share